Rhabdomyolysis is a syndrome involving the breakdown of skeletal muscle that causes myoglobin and other intracellular proteins to leak into the circulatory system, resulting in organ injury including acute kidney injury. We report a case of statin-induced rhabdomyolysis and acute kidney injury that developed in a 63-year-old woman with previously undiagnosed hypothyroidism. Untreated hypothyroidism may have caused her hypercholesterolemia requiring statin treatment, and it is postulated that statin-induced muscle injury was aggravated by hypothyroidism resulting in her full-blown rhabdomyolysis. Although this patient was successfully treated with continuous venovenous hemofiltration and L-thyroxin replacement, rhabdomyolysis with acute kidney injury is a potentially life-threatening disorder. Physicians must pay special attention to the possible presence of subclinical hypothyroidism when administering statins in patients with hypercholesterolemia.

Citations

Citations to this article as recorded by  

• Case report: Rhabdomyolysis and kidney injury in a statin-treated hypothyroid patient–kill two birds with one stone
  Wen-Fang Chiang, Jenq-Shyong Chan, Po-Jen Hsiao, Shih-Hua Lin
  Frontiers in Medicine.2022;[Epub]     CrossRef
• Secondary dyslipidemia: its treatments and association with atherosclerosis
  Hidekatsu Yanai, Hiroshi Yoshida
  Global Health & Medicine.2021; 3(1): 15.     CrossRef
• Hypothyroidism-associated rhabdomyolysis: A new case report and review of the reported cases
  FahmiYousef Khan, TheebOsama Sulaiman, RazaAli Akbar
  Imam Journal of Applied Sciences.2021; 6(2): 31.     CrossRef
• Phenotyping of Korean patients with better-than-expected efficacy of moderate-intensity statins using tensor factorization
  Jingyun Choi, Yejin Kim, Hun-Sung Kim, In Young Choi, Hwanjo Yu, Katriina Aalto-Setala
  PLOS ONE.2018; 13(6): e0197518.     CrossRef
• Discovery of potential novel microsomal triglyceride transfer protein inhibitors via virtual screening of pharmacophore modelling and molecular docking
  Ludi Jiang, Yusu He, Ganggang Luo, Yongqiang Yang, Gongyu Li, Yanling Zhang
  Molecular Simulation.2016; 42(15): 1223.     CrossRef
• Statin‐related aminotransferase elevation according to baseline aminotransferases level in real practice in Korea
  H.‐S. Kim, S. H. Lee, H. Kim, S.‐H. Lee, J. H. Cho, H. Lee, H. W. Yim, S.‐H. Kim, I.‐Y. Choi, K.‐H. Yoon, J. H. Kim
  Journal of Clinical Pharmacy and Therapeutics.2016; 41(3): 266.     CrossRef
• Creatinine as predictor value of mortality and acute kidney injury in rhabdomyolysis
  R. Baeza‐Trinidad, A. Brea‐Hernando, S. Morera‐Rodriguez, Y. Brito‐Diaz, S. Sanchez‐Hernandez, L. El Bikri, E. Ramalle‐Gomara, J. L. Garcia‐Alvarez
  Internal Medicine Journal.2015; 45(11): 1173.     CrossRef
• Brief Review of Articles in 'Endocrinology and Metabolism' in 2013
  Won-Young Lee
  Endocrinology and Metabolism.2014; 29(3): 251.     CrossRef
• The 2013 American College of Cardiology/American Heart Association guidelines for the treatment of dyslipidemia: mind the gaps!
  Vasilios G. Athyros, Niki Katsiki, Asterios Karagiannis, Dimitri P. Mikhailidis
  Current Medical Research and Opinion.2014; 30(9): 1701.     CrossRef